investig
effect
vaccin
male
beef
calv
mean
age
ae
sd
ae
bovin
herp
viru
ibr
viru
bovin
respiratori
synciti
viru
brsv
bovin
viral
diarrhea
bvd
viru
parainfluenza
pi
viru
incid
respiratori
diseas
first
forti
day
wean
enter
feedlot
portug
may
mertolenga
preta
mixedbre
calv
differ
beef
herd
systemat
assign
order
entranc
chute
two
treatment
group
move
common
feedlot
one
hundr
twenti
five
male
calv
vaccin
quadrival
vaccin
rispov
revaccin
day
herdmat
inject
salin
nacl
occas
incid
sever
clinic
case
bovin
respiratori
diseas
brd
evalu
everi
day
first
day
enter
feedlot
morbid
vs
mortal
vs
due
brd
significantli
lower
vaccin
group
ten
day
revaccin
calv
treat
antimicrobi
end
studi
outbreak
brd
caus
high
incid
diseas
nonvaccin
group
conclus
result
show
rispov
quadrival
vaccin
respiratori
virus
field
condit
reduc
morbid
mortal
due
brd
beef
calv
wean
respiratori
diseas
wean
feedlot
calv
bovin
respiratori
diseas
complex
brd
lead
caus
morbid
mortal
feedlot
worldwid
griffin
syndrom
complex
multifactori
aetiolog
usual
divid
three
major
categori
environment
factor
host
factor
infecti
factor
stilwel
elli
dyer
bacteria
haemolytica
p
multocida
caus
sever
ill
environment
factor
stress
lack
ventil
crowd
other
andor
virus
reduc
capac
anim
control
infect
storz
et
al
thomson
although
environment
factor
crucial
origin
brd
address
prevent
program
engelken
control
usual
harder
achiev
manag
infecti
element
diseas
main
reason
although
etiopathogenesi
diseas
well
known
beef
produc
depend
much
antimicrobi
vaccin
control
brd
continu
use
antimicrobi
mani
disadvantag
elli
brumbaugh
expens
ineffici
risk
antimicrobi
resist
threat
anim
welfar
control
bacteri
stage
diseas
consequ
follow
administr
antimicrobi
even
prophylact
approach
kept
situat
control
brd
possibl
mean
vaccin
respiratori
virus
seem
sensibl
prudent
approach
especi
forecast
moment
import
immun
suppress
associ
virus
wean
group
young
anim
differ
herd
dyer
howev
use
vaccin
control
brd
anim
arriv
feedlot
still
controversi
elli
occasion
use
europ
seldom
use
portug
person
observ
econom
benefit
vaccin
brd
fulli
demonstr
smith
et
al
although
import
factor
eg
anim
welfar
consid
mani
studi
tizard
vaccin
trial
conduct
control
condit
follow
experiment
infect
field
studi
contrari
still
scarc
engelken
respiratori
virus
commonli
respons
brd
includ
bovin
herp
infecti
bovin
rinotrach
ibr
bovin
respiratori
synciti
viru
brsv
bovin
viral
diarrhea
bvd
viru
parainfluenza
pi
viru
storz
et
al
virus
implic
pathogenesi
brd
includ
coronaviru
adenoviru
parvoviru
rhinoviru
storz
et
al
smith
et
al
virus
known
involv
brd
sole
synerg
bacteria
affect
lung
parenchyma
directli
brsv
pi
other
act
immun
system
bvd
brsv
local
defenc
ibr
like
ciliat
epithelium
characterist
role
virus
pathogenesi
brd
well
document
elli
baker
et
al
smith
et
al
thomson
howev
field
usual
difficult
identifi
viru
virus
implic
outbreak
brd
especi
feedlot
condit
main
reason
multival
vaccin
prefer
object
evalu
benefit
multival
vaccin
rispov
pfizer
anim
health
four
respiratori
virus
compar
morbid
incid
mortal
clinic
case
brd
group
vaccin
nonvaccin
male
beef
calv
day
feedlot
wean
calv
differ
herd
ribatejo
region
portug
calv
mean
age
wean
overal
breed
present
tabl
wean
calv
born
winter
take
place
may
day
wean
calv
transport
one
nearbi
feedlot
morbid
due
brd
alway
unit
mortal
reach
month
follow
wean
calv
kept
open
barn
slate
concret
floor
feed
includ
commerci
cornbas
concentr
alfalfa
hay
water
alway
avail
histori
herd
show
vaccin
respiratori
virus
ever
perform
best
vaccin
program
would
administ
first
dose
three
week
wean
revaccin
day
wean
engelken
howev
main
object
test
efficaci
vaccin
field
condit
vaccin
wean
day
revaccin
day
later
practic
schedul
vaccin
use
rispov
pfizer
contain
follow
wean
day
male
calv
vaccin
intramuscularli
ml
rispov
receiv
intramuscular
inject
salin
solut
calf
show
sign
ill
excel
bodi
condit
herd
male
wean
move
race
altern
alloc
two
treatment
group
order
entranc
first
alway
alloc
nonvaccin
group
two
herd
due
vaccin
unavail
last
calv
last
chute
includ
nonvaccin
group
contrast
last
four
calv
two
mertolenga
herd
vaccin
use
last
dose
alreadi
open
bottl
vaccin
first
dose
vaccin
administ
may
wean
herd
occur
period
second
june
schedul
calv
revaccin
day
first
dose
distribut
calv
vaccin
nonvaccin
present
tabl
anim
inspect
daili
herdsmen
blind
studi
sick
suspect
calv
separ
clinic
evalu
select
anim
antimicrobi
treatment
made
feedlot
veterinarian
blind
studi
clinic
sign
use
select
brdaffect
anim
isol
herdmat
decreas
appetit
depress
first
sign
detect
herdsman
dyspnea
cough
nasal
ocular
discharg
hyperthermia
result
vetconduct
physic
examin
anim
show
sign
albeit
differ
sever
includ
brdaffect
group
four
sudden
death
occur
also
consid
brd
blind
postmortem
confirm
extens
pulmonari
lesion
anim
consid
brd
posit
isol
treat
antimicrobi
tilmicosin
mgkg
bw
subcutan
nonsteroid
antiinflammatori
drug
flunixin
meglumin
mgkg
bw
subcutan
lung
three
dead
anim
sent
microbiolog
histopatholog
exam
appropri
laboratori
faculdad
de
medicina
veterinaria
de
lisboa
lab
personnel
blind
studi
number
morbid
mortal
due
brd
submit
logisticregress
analysi
proc
logist
proc
genmod
respect
use
sa
softwar
sa
effect
vaccin
breed
calf
age
vaccin
covari
respect
interact
includ
logist
multipl
regress
model
wald
chisquar
test
use
assess
import
factor
signific
effect
p
shown
interact
remov
model
need
use
proc
genmod
mortal
due
fact
data
show
quasicomplet
separ
problem
data
complet
partial
separ
may
possibl
obtain
reliabl
maximum
likelihood
estim
converg
may
occur
converg
occur
one
paramet
model
becom
theoret
infinit
case
model
perfectli
predict
respons
paramet
model
estim
data
spars
webb
et
al
result
tabl
show
data
concern
morbid
mortal
first
day
wean
first
vaccin
mean
age
wean
onset
diseas
compar
calv
got
sick
differ
day
studi
logisticregress
analysi
tabl
show
vaccin
signific
effect
p
morbid
mortal
due
brd
odd
ratio
nonvaccin
vaccin
anim
show
former
like
get
brd
age
weaningvaccin
also
signific
effect
respiratori
diseas
incid
p
slope
coeffici
ae
repres
chang
log
odd
liabil
per
unit
increas
age
day
odd
ratio
age
show
older
calv
less
like
get
brd
fig
breed
effect
morbid
mortal
calv
show
sign
brd
throughout
studi
period
mortal
especi
high
hot
day
outbreak
june
day
first
group
wean
decid
finish
trial
major
anim
treat
antibiot
mgkg
bw
tilmicosin
tri
control
mortal
moment
onward
studi
compar
suscept
brd
consid
close
report
treatment
death
due
brd
outbreak
previous
describ
postmortem
examin
perform
four
anim
die
three
differ
day
second
vaccin
gross
lesion
includ
pleurisi
emphysema
oedema
especi
evid
dorsal
lobe
thick
interlobular
septa
sign
bronchopneumonia
cranioventr
lung
lung
three
dead
anim
sent
histopatholog
exam
fourth
anim
dead
long
felt
laboratori
analys
go
use
microscop
exam
show
pleurisi
lesion
traqueiti
pseudomembran
intens
prolifer
submucosa
lymphoid
tissu
pronounc
hyperplasia
peribronch
lymphoid
tissu
balt
hyperplasia
bronchiolar
alveolar
epithelium
oedemat
emphysematos
alveol
show
larg
number
multinucl
giant
cell
syncyti
cell
bacterium
found
two
sampl
sent
microbiolog
one
reveal
p
multocida
viru
isol
attempt
studi
slightli
affect
durat
need
treat
anim
day
perman
feedlot
outbreak
clinic
respiratori
diseas
sever
affect
nonvaccin
popul
tabl
outbreak
end
studi
occur
day
second
dose
vaccin
given
last
wean
calv
day
revaccin
first
wean
calv
studi
promot
advers
condit
vaccin
group
would
occur
anim
vaccin
viru
shed
circul
heavier
half
popul
vaccin
perspect
nonvaccin
calv
favour
rel
lower
circul
viru
compar
situat
anim
vaccin
spite
drawback
vaccin
efficaci
demonstr
reduc
incid
brd
mortal
due
respiratori
diseas
calv
recent
wean
tabl
odd
ratio
analysi
also
show
anim
wean
older
age
less
like
show
respiratori
diseas
especi
evid
nonvaccin
group
fig
clinic
sign
necropsi
lesion
histopatholog
exam
suggest
least
one
respiratori
virus
brsv
involv
brd
case
use
live
vaccin
viru
seem
appropri
vaccin
close
wean
transport
commingl
rapid
immun
respons
conclus
vaccin
rispov
reduc
morbid
mortal
associ
brd
calv
recent
wean
commingl
feedlot
